A recent small cohort study published in Clinical Science seems to indicate that eating a large breakfast can have a positive impact on fertility in women with Polycystic Ovary Syndrome (PCOS).
Researchers from Hebrew University of Jerusalem and Tel Aviv University studied 60 women over a 12-week period. Study participants were aged 25 to 39 years, had a lean body with a body mass index <23, and had PCOS. The women were split into two groups and allowed to consume a diet of 1800 calories per day. The breakfast group consumed the bulk of their calories-roughly 980-with their morning meal and the dinner group consumed those calories with their evening meal. All participants kept a record of all food consumed during the study.
The breakfast group saw a significant decrease in AUCglucose (glucose area under the curve) and AUCinsulin(insulin area under the curve): 7% and 54%, respectively. Free testosterone decreased by 50% and sex hormone-binding globulin increased 105%. An increased ovulation rate was seen in the breakfast group. None of these measurements changed in the dinner group.
The study authors concluded that a high-calorie breakfast and reduced-calorie dinner leads to greater insulin sensitivity indices and increased ovarian cytochrome P450c17α, which helps reduce the hyperandrogenism resulting from PCOS.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
Tailored hormone therapy improves postoperative endometriosis outcomes
October 3rd 2024A recent study suggests that postoperative endometriosis patients experience improved quality of life through hormone therapies guided by optimizing treatment based on individual hormonal receptor profiles.
Read More
CD outcomes similar between single- vs double-layer uterine closure
September 24th 2024In a recent study, similar rates of live birth and other pregnancy outcomes were reported between patients receiving double- vs single-layer uterine closure following cesarean delivery, indicating a lack of superiority from a single method.
Read More
Study reports reduced SSI odds after gynecologic surgery from metronidazole and cefazolin
September 19th 2024A recent study shows that adding metronidazole to cefazolin significantly lowers the risk of surgical site infections in gynecologic cancer surgeries, enhancing patient outcomes.
Read More
Phase 2b safety data for Sildenafil Cream against FSAD reported
August 26th 2024In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.
Read More